Clinical Trials

The Lynn Institute of the Rockies is an emerging leader bringing new drugs to the market with its clinical trials program. The Lynn Institute has extensive experience in a number of areas: chronic digestive diseases such as heartburn, ulcers and irritable bowel syndrome; cardiovascular diseases and hypertension; disorders such as asthma, lung infections and cystic fibrosis; women's health; urology; rheumatoid and osteoarthritis; sleep disorders such as apnea, insomnia and narcolepsy. The Lynn Institute has conducted studies of numerous prescription drugs and over-the-counter medications. At any point in time, the Institute may be involved in as many as 50 clinical trials or more.

The Lynn Institute of the Rockies has a large patient volunteer database.  This facilitates the quick start-up, enrollment and matching of patients for studies so trials can get started and completed sooner. The Lynn Institute has 8 Clinical Research Coordinators on staff.

The Lynn Institute of the Rockies focuses on Phase II, III and IV studies in the following areas:

Sleep Disorders

  • Insomnia                  
  • Narcolepsy
  • Restless Legs
  • Sleep Apnea

Gastrointestinal

  • Ulcerative Colitis
  • IBS
  • GERD
  • Chronic Constipation
  • Crohn’s Disease
  • Dyspepsia
  • Erosive Esophagitis

CNS

  • Generalized Anxiety Disorder
  • Depression
  • Anxiety
  • ADHD
  • Phobia
  • Alzheimer
  • Schizophrenia
  • Bi-Polar

Arthritis

  • Ankylosing Spondylitis
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Fibromyalgia

Women’s Health

  • Osteoporosis
  • Endometriosis
  • Urinary Tract Infection
  • Genital Herpes
  • Menopause
  • Mastalgia
  • Birth Control
  • Incontinence
  • HPV
  • Hormone Replacement
  • Overactive Bladder
  • Menorrhagia

Dermatology

  • Rosacea
  • Acne
  • Psoriasis

Other

  • Smoking Cessation
  • Pediatrics
  • Tinea Pedis
  • Hypertension
  • Obesity
  • Vaccination
  • Herpes Zoster